FI50789C - Menetelmä farmakologisesti vaikuttavien 2-alkoksi-3,5-dihalogeenibents eenien valmistamiseksi. - Google Patents

Menetelmä farmakologisesti vaikuttavien 2-alkoksi-3,5-dihalogeenibents eenien valmistamiseksi.

Info

Publication number
FI50789C
FI50789C FI690407A FI40769A FI50789C FI 50789 C FI50789 C FI 50789C FI 690407 A FI690407 A FI 690407A FI 40769 A FI40769 A FI 40769A FI 50789 C FI50789 C FI 50789C
Authority
FI
Finland
Prior art keywords
dihalobenzenes
alkoxy
preparation
pharmacologically active
pharmacologically
Prior art date
Application number
FI690407A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI50789B (xx
Inventor
Michel Thominet
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR151632A external-priority patent/FR7615M/fr
Application filed by Ile De France filed Critical Ile De France
Publication of FI50789B publication Critical patent/FI50789B/fi
Application granted granted Critical
Publication of FI50789C publication Critical patent/FI50789C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Insulating Bodies (AREA)
FI690407A 1968-02-16 1969-02-10 Menetelmä farmakologisesti vaikuttavien 2-alkoksi-3,5-dihalogeenibents eenien valmistamiseksi. FI50789C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR140294 1968-02-16
FR151632A FR7615M (xx) 1968-05-10 1968-05-10

Publications (2)

Publication Number Publication Date
FI50789B FI50789B (xx) 1976-03-31
FI50789C true FI50789C (fi) 1976-07-12

Family

ID=26181810

Family Applications (1)

Application Number Title Priority Date Filing Date
FI690407A FI50789C (fi) 1968-02-16 1969-02-10 Menetelmä farmakologisesti vaikuttavien 2-alkoksi-3,5-dihalogeenibents eenien valmistamiseksi.

Country Status (21)

Country Link
JP (1) JPS4934669B1 (xx)
BE (1) BE728221A (xx)
BG (1) BG15205A3 (xx)
BR (1) BR6906462D0 (xx)
CA (1) CA928299A (xx)
CH (1) CH490328A (xx)
CS (1) CS155198B2 (xx)
DK (1) DK125020B (xx)
ES (1) ES363662A1 (xx)
FI (1) FI50789C (xx)
GB (1) GB1251695A (xx)
IE (1) IE32961B1 (xx)
IL (1) IL31594A (xx)
LU (1) LU58009A1 (xx)
MC (1) MC809A1 (xx)
NL (1) NL138921B (xx)
NO (1) NO128958B (xx)
OA (1) OA03885A (xx)
SE (1) SE367184B (xx)
YU (1) YU33793B (xx)
ZM (1) ZM969A1 (xx)

Also Published As

Publication number Publication date
IL31594A (en) 1973-02-28
ZM969A1 (en) 1969-11-17
CS155198B2 (xx) 1974-05-30
FI50789B (xx) 1976-03-31
JPS4934669B1 (xx) 1974-09-17
CA928299A (en) 1973-06-12
OA03885A (fr) 1975-08-14
ES363662A1 (es) 1971-01-01
DK125020B (da) 1972-12-18
SE367184B (xx) 1974-05-20
BR6906462D0 (pt) 1973-01-16
NL138921B (nl) 1973-05-15
MC809A1 (fr) 1970-07-30
BE728221A (xx) 1969-08-11
IE32961B1 (en) 1974-02-06
NO128958B (xx) 1974-02-04
IE32961L (en) 1969-08-16
LU58009A1 (xx) 1969-09-18
NL6902401A (xx) 1969-08-19
IL31594A0 (en) 1969-04-30
YU33793B (en) 1978-05-15
CH490328A (fr) 1970-05-15
DE1906551B2 (de) 1975-07-17
YU33269A (en) 1977-10-31
GB1251695A (xx) 1971-10-27
DE1906551A1 (de) 1969-08-21
BG15205A3 (bg) 1972-05-20

Similar Documents

Publication Publication Date Title
FI51347C (fi) Menetelmä 1-substituoitujen-3- ja -4-aroyylipiperidiinien valmistamise ksi.
FI50707C (fi) Menetelmä uusien farmakologisesti vaikuttavien hydroksisykloheksyyliam iinien valmistamiseksi.
FI49503C (fi) Analogiamenetelmä 1,2,3,4-tetrahydro-4-fenyyli-isokinoliinijohdannaist en valmistamiseksi.
FI45966C (fi) Menetelmä kokkiostaattisesti aktiivisten 4-hydroksi-6,7-dialkoksi-3-ka rboalkoksikinoliinien valmistamiseksi.
FI48588C (fi) Analogiamenetelmä terapeuttisesti vaikuttavien 3,4-dihydroisokinoliini johdannaisten valmistamiseksi.
FI44801C (fi) Menetelmä uusien, terapeuttisesti vaikuttavien, emäksisten eettereiden valmistamiseksi.
FI49504C (fi) Menetelmä farmakologisesti vaikuttavien bensosykloheptaisokinoliinijoh dannaisten valmistamiseksi.
FI51342C (fi) Menetelmä uusien, terapeuttisesti vaikuttavien hydroksifenyylialkyylia miinijohdannaisten valmistamiseksi.
FI51179C (fi) Menetelmä uusien hypoglykeemisesti vaikuttavien 1-(p-asyyliaminoalkyyl i-fenyylisulfonyyli)-2-imino-imidatsolidiinien valmistamiseksi.
DK122760B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 4-alkoxy-3,5-dimethoxybenzamider.
DK125464C (da) Analogifremgangsmåde til fremstilling af 6-halogen-15β, 16β-methylen-pregnanderivater.
FI51349C (fi) Menetelmä terapeuttisesti vaikuttavien N-substituoitujen 6,7-bentsomor faanien valmistamiseksi.
FI50630C (fi) Menetelmä farmakologisesti vaikuttavien 2,3,4,4a-tetrahydro-10H-1,2-ok satsino (3,2-b) (1,3) bentsoksatsiini-10-onien valmistamiseksi.
FI49417C (fi) Menetelmä farmakologisesti aktiivisten 2,3-dihydro-bentsofuraani-2-kar bonihappojen valmistamiseksi.
FI52096C (fi) Menetelmä analgeettisesti aktiivisten 2,3-dihydrotiatsolo(3.2.a)pyrimi diini-5-onien valmistamiseksi
DK124679B (da) Analogifremgangsmåde til fremstilling af hjertevirksomme 4,5-epoxy-14β-hydroxybufa-20,22-dienolider.
FI48842C (fi) Menetelmä farmakologisesti aktiivisten 6-kloori-1H-2,3-bentsoksatsiini en valmistamiseksi.
FI50710C (fi) Menetelmä 1,4-bentsodiatsepiinien valmistamiseksi.
FI49038C (fi) Analogiamenetelmä uusien, farmakologisesti aktiivisten 4-fenyyli-1H-ki natsoliini-2-oni-johdannaisten valmistamiseksi.
FI50789C (fi) Menetelmä farmakologisesti vaikuttavien 2-alkoksi-3,5-dihalogeenibents eenien valmistamiseksi.
FI46723C (fi) Menetelmä 1,18-dimetyyli-5alfa-H-androst-1-eenijohdannaisten valmistam iseksi.
FI46066C (fi) Analogiamenetelmä terapeuttisesti vaikuttavien N,N-dimetyyliamino-etyy li-14beta-hydroksi-5beta-pregn-20-eeni-21-karboksylaattien valmistamis eksi.
FI48732C (fi) Menetelmä farmakologisesti aktiivisten 3-substituoitu-amino-1,2,3,4-te trahydrokarbatsolien valmistamiseksi.
FI43987C (fi) Menetelmä farmakologisesti tehokkaiden 10-aminoalkyyli-dibents (b,f)atsepiinijohdannaisten valmistamiseksi
FI45324C (fi) Menetelmä 17beta-(1-alkoksi-sykloalkyyli)oksi-2alfa,3alfa-epitio-5alfa -androstaanien valmistamiseksi.